Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
F2 Vision SCS
10% owner at Cullinan Therapeutics. Filing since 12 May 2022.
CIK 0001838409
Company
Date
Role
Action
Shares
Amount
Of holding
CGEM
Cullinan Therapeutics, Inc.
4 Aug 2022
10% owner
Sold, plan not stated
25,989
$371.79K
2.0%
CGEM
Cullinan Therapeutics, Inc.
3 Aug 2022
10% owner
Sold, plan not stated
19,129
$272.33K
1.5%
CGEM
Cullinan Therapeutics, Inc.
2 Aug 2022
10% owner
Sold, plan not stated
4,792
$67.55K
0.4%
CGEM
Cullinan Therapeutics, Inc.
16 May 2022
10% owner
Sold, plan not stated
35,158
$394.83K
2.6%
CGEM
Cullinan Therapeutics, Inc.
13 May 2022
10% owner
Sold, plan not stated
119,508
$1.21M
8.2%
CGEM
Cullinan Therapeutics, Inc.
12 May 2022
10% owner
Sold, plan not stated
264,072
$2.44M
15.3%
6 decisions on file.
